X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-11 | MMSI | Merit Medical Systems Inc | Smith Christian Adam | Chief Commercial Officer | P - Purchase | $61.00 | +1,626 | 32,554 | +5% | +$99,186 | |||||
2026-05-12 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.34 | +475,000 | 10,453,988 | +5% | +$636,500 | ||||||
| M | 2026-05-08 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.16 | +75,626 | 1,056,575 | +8% | +$88,026 | |||||
| D | 2026-05-11 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | P - Purchase | $10.71 | +5,312 | 20,299 | +35% | +$56,892 | |||||
| D | 2026-05-11 | IRTC | Irhythm Holdings, Inc. | Talwalkar Abhijit Y | Dir | S - Sale+OE | $117.93 | -5,312 | 20,299 | -21% | -$626,430 | |||||
| D | 2026-05-11 | SYK | Stryker Corp | Fink M Kathryn | VP, CHRO | S - Sale+OE | $283.69 | -8,720 | 13,758 | -39% | -$2,473,756 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Osage University Gp Iii, LLC | 10% | P - Purchase | $15.00 | +533,333 | 1,404,183 | +61% | +$7,999,995 | |||||
2026-05-12 | SRTS | Sensus Healthcare, Inc. | Sachetta Eric | Dir | P - Purchase | $3.34 | +1,500 | 145,706 | +1% | +$5,003 | ||||||
2026-05-08 | INFU | Infusystem Holdings, Inc | Gendron Paul Andrew | Dir | P - Purchase | $8.88 | +5,000 | 70,000 | +8% | +$44,400 | ||||||
| M | 2026-05-08 | INFU | Infusystem Holdings, Inc | Lachance Carrie | Pres, CEO | P - Purchase | $8.71 | +3,000 | 473,246 | +1% | +$26,120 | |||||
2026-05-08 | INFU | Infusystem Holdings, Inc | Steele Barry G | EVP, CFO | P - Purchase | $8.71 | +7,000 | 186,180 | +4% | +$60,949 | ||||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Tansey Casey M | Dir, 10% | P - Purchase | $15.00 | +66,666 | 3,860,158 | +2% | +$999,990 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Harrington William T | Dir, 10% | P - Purchase | $15.00 | +533,333 | 1,404,183 | +61% | +$7,999,995 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Lucchese Cynthia L | Dir | P - Purchase | $15.00 | +125,000 | 125,000 | New | +$1,875,000 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Leavitt Chase C. | See Remarks | P - Purchase | $15.00 | +3,000 | 3,000 | New | +$45,000 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Mead Dana G Jr. | Dir | P - Purchase | $15.00 | +7,000 | 7,000 | New | +$105,000 | |||||
| A | 2026-05-11 | PLSE | Pulse Biosciences, Inc. | Laviolette Paul A | CEO | P - Purchase | $19.69 | +15,000 | 15,846 | >999% | +$295,350 | |||||
| M | 2026-05-07 | ATEC | Alphatec Holdings, Inc. | Valentine Keith | Dir | P - Purchase | $7.38 | +135,000 | 232,271 | +139% | +$996,192 | |||||
2026-05-11 | PLSE | Pulse Biosciences, Inc. | Laviolette Paul A | CEO | P - Purchase | $19.69 | +15,000 | 15,000 | New | +$295,350 | ||||||
2026-05-11 | PLSE | Pulse Biosciences, Inc. | Duggan Robert W | Dir, 10% | P - Purchase | $19.69 | +660,233 | 49,291,731 | +1% | +$12,999,988 | ||||||
| M | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $108.27 | -46,481 | 1,463,419 | -3% | -$5,032,413 | |||||
2026-05-08 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale | $107.00 | -2,928 | 3,749 | -44% | -$313,287 | ||||||
| D | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Ross Bridget A | Dir | S - Sale+OE | $111.10 | -5,044 | 3,942 | -56% | -$560,366 | |||||
| D | 2026-05-07 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale+OE | $110.00 | -3,943 | 4,714 | -46% | -$433,730 | |||||
2026-05-08 | INSP | Inspire Medical Systems, Inc. | McCormick Shawn | Dir | S - Sale | $45.31 | -696 | 30,712 | -2% | -$31,536 | ||||||
2026-05-11 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.06 | +150,000 | 11,085,090 | +1% | +$9,270 | ||||||
2026-05-07 | MMSI | Merit Medical Systems Inc | Ward Lynne N. | Dir | S - Sale | $62.61 | -5,000 | 7,809 | -39% | -$313,035 | ||||||
| D | 2026-05-07 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | P - Purchase | $62.63 | +2,000 | 64,132 | +3% | +$125,250 | |||||
| D | 2026-05-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $207.82 | -4,991 | 468,313 | -1% | -$1,037,233 | |||||
| M | 2026-05-06 | NSPR | Inspiremd, Inc. | Ward Scott R. | Dir | P - Purchase | $1.15 | +89,250 | 237,096 | +60% | +$102,638 | |||||
| M | 2026-05-06 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $1.14 | +7,895 | 531,599 | +2% | +$9,034 | |||||
2026-05-07 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $1.18 | +90,000 | 834,478 | +12% | +$106,200 | ||||||
2026-05-07 | OFIX | Orthofix Medical Inc. | Henneman John B III | Dir | P - Purchase | $12.26 | +5,000 | 90,809 | +6% | +$61,295 | ||||||
| M | 2026-05-05 | OFIX | Orthofix Medical Inc. | Engine Capital Management, LP | 10% | P - Purchase | $12.08 | +184,896 | 4,575,675 | +4% | +$2,232,927 | |||||
2026-05-06 | MMSI | Merit Medical Systems Inc | Aronson Martha Goldberg | Pres, CEO | P - Purchase | $60.44 | +2,000 | 49,792 | +4% | +$120,880 | ||||||
| D | 2026-05-06 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | P - Purchase | $61.01 | +1,500 | 61,542 | +2% | +$91,515 | |||||
| D | 2026-05-05 | MMSI | Merit Medical Systems Inc | Voigt Michel J. | CHRO | P - Purchase | $60.65 | +2,250 | 48,392 | +5% | +$136,463 | |||||
| M | 2026-05-04 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $85.71 | -7,500 | 4,412,950 | 0% | -$642,862 | |||||
2026-05-01 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $3.00 | -16,667 | 1,673,374 | -1% | -$50,001 | ||||||
2026-05-04 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $13.15 | -337 | 89,748 | 0% | -$4,432 | ||||||
2026-05-04 | IRTC | Irhythm Holdings, Inc. | Lawrence Brian Lee | CTO | S - Sale | $120.80 | -1,014 | 20,154 | -5% | -$122,491 | ||||||
| D | 2026-04-30 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale+OE | $140.00 | -10,000 | 43,681 | -19% | -$1,400,000 | |||||
2026-05-01 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale | $143.54 | -19,573 | 73,419 | -21% | -$2,809,508 | ||||||
2026-05-01 | GKOS | Glaukos Corp | Wen Leana | Dir | S - Sale | $143.35 | -1,700 | 19,739 | -8% | -$243,695 | ||||||
| M | 2026-04-30 | SNWV | Sanuwave Health, Inc. | Opaleye Management Inc. | 10% | S - Sale | $16.14 | -35,581 | 858,569 | -4% | -$574,240 | |||||
2026-05-01 | ANIK | Anika Therapeutics, Inc. | Henneman John B III | Dir | P - Purchase | $14.66 | +5,000 | 54,871 | +10% | +$73,320 | ||||||
| M | 2026-04-28 | HTFL | Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC | 10% | S - Sale | $29.45 | -2,000,000 | 8,448,158 | -19% | -$58,898,336 | |||||
2026-04-30 | ANIK | Anika Therapeutics, Inc. | Griffin Stephen D. | Pres, CEO | P - Purchase | $12.29 | +12,200 | 36,163 | +51% | +$149,881 | ||||||
| M | 2026-04-28 | SNWV | Sanuwave Health, Inc. | Opaleye Management Inc. | 10% | S - Sale | $18.05 | -70,648 | 894,150 | -7% | -$1,274,971 | |||||
| M | 2026-04-27 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $87.69 | -7,500 | 4,420,450 | 0% | -$657,709 | |||||
| D | 2026-04-27 | OBIO | Orchestra Biomed Holdings, Inc. | Rtw Investments, LP | 10% | S - Sale+OE | $4.13 | -32 | 9,556,063 | 0% | -$132 | |||||
| D | 2026-04-27 | WST | West Pharmaceutical Services Inc | Favorite Annette F | SVP, CHRO | S - Sale+OE | $305.20 | -2,817 | 21,795 | -11% | -$859,753 | |||||
| D | 2026-04-27 | WST | West Pharmaceutical Services Inc | Winters Chad | VP, Chief Accounting Officer | S - Sale+OE | $300.67 | -896 | 1,523 | -37% | -$269,399 | |||||
2026-04-27 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $151.94 | -74 | 21,159 | 0% | -$11,244 | ||||||
| A | 2026-04-16 | BEAT | Heartbeam, Inc. | Ferrari Richard | Dir | P - Purchase | $0.80 | +57,500 | 286,636 | +25% | +$46,000 | |||||
| M | 2026-04-20 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $92.55 | -7,500 | 4,427,950 | 0% | -$694,124 | |||||
| M | 2026-04-20 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.55 | +200,000 | 9,978,988 | +2% | +$309,000 | |||||
| M | 2026-04-17 | SNWV | Sanuwave Health, Inc. | Opaleye Management Inc. | 10% | S - Sale | $20.46 | -16,469 | 964,798 | -2% | -$336,982 | |||||
2026-04-16 | OFIX | Orthofix Medical Inc. | Cedron Jorge Andres | CLO | S - Sale | $12.82 | -3,743 | 59,006 | -6% | -$47,985 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Cruickshank Tim | CFO | P - Purchase | $0.80 | +31,250 | 72,230 | +76% | +$25,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Elfrink Willem | Dir | P - Purchase | $0.80 | +187,500 | 538,667 | +53% | +$150,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Jaff Michael R | Dir | P - Purchase | $0.80 | +31,250 | 31,250 | New | +$25,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Vajdic Branislav | Dir | P - Purchase | $0.80 | +31,250 | 909,914 | +4% | +$25,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Ferrari Richard | Dir | P - Purchase | $0.80 | +62,500 | 291,636 | +27% | +$50,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Eno Robert Paul | Pres | P - Purchase | $0.80 | +12,500 | 36,742 | +52% | +$10,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Ortigas-Wedekind Marga | Dir | P - Purchase | $0.80 | +25,000 | 137,293 | +22% | +$20,000 | ||||||
2026-04-16 | BEAT | Heartbeam, Inc. | Strome Mark E | Dir | P - Purchase | $0.80 | +750,000 | 3,650,000 | +26% | +$600,000 | ||||||
2026-04-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $63.04 | -1,700 | 111,204 | -2% | -$107,168 | ||||||
2026-04-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $20.04 | -15,000 | 349,786 | -4% | -$300,671 | ||||||
| M | 2026-04-13 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $92.96 | -7,500 | 4,435,450 | 0% | -$697,189 | |||||
2026-04-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $26.72 | -22,562 | 549,163 | -4% | -$602,857 | ||||||
2026-04-10 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $117.62 | -2,093 | 90,370 | -2% | -$246,175 | ||||||
2026-04-06 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $3.55 | -7,231 | 230,939 | -3% | -$25,670 | ||||||
2026-04-06 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $3.55 | -13,761 | 369,770 | -4% | -$48,852 | ||||||
| M | 2024-05-30 | MMM | 3M Co | Goralski Christian T Jr | Group Pres | P - Purchase | $107.18 | +17 | 6,971 | 0% | +$1,822 | |||||
| D | 2026-04-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $225.50 | -4,991 | 468,313 | -1% | -$1,125,486 | |||||
| M | 2026-04-06 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $95.63 | -7,500 | 4,442,950 | 0% | -$717,208 | |||||
2026-04-02 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $328.22 | -100 | 8,719 | -1% | -$32,822 | ||||||
| D | 2026-04-01 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $24.64 | -64,533 | 226,542 | -22% | -$1,590,093 | |||||
2026-04-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $12.87 | -3,318 | 263,148 | -1% | -$42,708 | ||||||
| M | 2026-04-01 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $12.91 | -3,134 | 282,840 | -1% | -$40,466 | |||||
2026-04-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $3.48 | -25,874 | 701,621 | -4% | -$90,042 | ||||||
2026-04-02 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $3.48 | -8,168 | 1,990,290 | 0% | -$28,425 | ||||||
2026-04-01 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $3.70 | -2,869 | 267,807 | -1% | -$10,615 | ||||||
2026-04-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $3.70 | -29,244 | 6,151,156 | 0% | -$108,203 | ||||||
2026-04-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $224.31 | -1,000 | 83,495 | -1% | -$224,310 | ||||||
| D | 2026-03-31 | VVOS | Vivos Therapeutics, Inc. | Skaff Michael C | 10% | P - Purchase | $1.34 | +1,353,625 | 1,353,625 | New | +$1,813,858 | |||||
2026-04-01 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $225.00 | -2,000 | 60,773 | -3% | -$450,000 | ||||||
2026-03-31 | PLRZ | Polyrizon Ltd. | Izraeli Tomer | CEO | S - Sale | $11.85 | -500 | 31,512 | -2% | -$5,925 | ||||||
2026-03-31 | PLRZ | Polyrizon Ltd. | Carmel Liron | Dir | S - Sale | $12.36 | -942 | 3,127 | -23% | -$11,643 | ||||||
2026-03-31 | PLRZ | Polyrizon Ltd. | Adler Oz | Dir | S - Sale | $12.05 | -3,292 | 19,850 | -14% | -$39,669 | ||||||
2026-03-30 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Business Development Dir | S - Sale | $0.74 | -15,363 | 198,667 | -7% | -$11,369 | ||||||
2026-03-30 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $95.02 | -7,500 | 4,450,450 | 0% | -$712,614 | ||||||
2026-03-30 | PLRZ | Polyrizon Ltd. | Carmel Liron | Dir | S - Sale | $11.00 | -100 | 4,069 | -2% | -$1,100 | ||||||
2026-03-30 | PLRZ | Polyrizon Ltd. | Izraeli Tomer | CEO | S - Sale | $10.90 | -3,900 | 32,012 | -11% | -$42,510 | ||||||
2026-03-30 | PLRZ | Polyrizon Ltd. | Turgeman Tidhar | CTO | S - Sale | $10.90 | -2,917 | 17,518 | -14% | -$31,795 | ||||||
| D | 2026-03-26 | VERO | Venus Concept Inc. | Madryn Asset Management, LP | 10% | P - Purchase | $0.04 | +37,537,187 | 37,547,373 | >999% | +$1,500,000 | |||||
2026-03-30 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.25 | +385,442 | 9,778,988 | +4% | +$481,803 | ||||||
2026-03-26 | KMTS | Kestra Medical Technologies, Ltd. | Cohen Raymond W | Dir | P - Purchase | $19.98 | +10,000 | 50,903 | +24% | +$199,800 | ||||||
2026-03-27 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.35 | +500,000 | 9,393,276 | +6% | +$675,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |